logo
ResearchBunny Logo
Experiences of pregnant women with genome-wide non-invasive prenatal testing in a national screening program

Medicine and Health

Experiences of pregnant women with genome-wide non-invasive prenatal testing in a national screening program

K. R. M. V. D. Meij, Q. Y. F. V. D. Pol, et al.

Join researchers Karuna R. M. van der Meij and colleagues as they explore the preferences of 423 pregnant women in a national screening program for non-invasive prenatal testing. Discover why an overwhelming majority chose genome-wide testing over targeted options and their thoughts on future screening possibilities.

00:00
00:00
Playback language: English
Abstract
This study evaluated women’s experiences with genome-wide (GW) first-tier non-invasive prenatal testing (NIPT) in a national screening program. 423 pregnant women chose between targeted NIPT (trisomies 21, 18, and 13) and GW-NIPT. Most (90.4%) were glad to have the choice; 76.5% chose GW-NIPT, mainly to get as much information as possible. Those choosing targeted NIPT primarily wanted to avoid uncertainty. Anxiety levels were similar between groups. Most favored broader future screening.
Publisher
European Journal of Human Genetics
Published On
Jan 01, 2023
Authors
Karuna R. M. van der Meij, Qiu Ying. F. van de pol, Mireille N. Bekker, Linda Martin, Janneke Gitsels-van der Wal, Elsbeth H. van Vliet-Lachotzki, Janneke M. Weiss, Robert-Jan H. Galjaard, Erik A. Sistermans, Merryn V. E. Macville, Lidewij Henneman, the Dutch NIPT Consortium
Tags
non-invasive prenatal testing
genome-wide testing
targeted NIPT
pregnancy screening
women's health
choice in testing
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny